1. Home
  2. OGN vs CBZ Comparison

OGN vs CBZ Comparison

Compare OGN & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.49

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo CBIZ Inc.

CBZ

CBIZ Inc.

HOLD

Current Price

$31.29

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
CBZ
Founded
1923
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
OGN
CBZ
Price
$13.49
$31.29
Analyst Decision
Hold
Hold
Analyst Count
5
3
Target Price
$11.40
$41.33
AVG Volume (30 Days)
2.4M
675.1K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
134.62
EPS
0.55
1.83
Revenue
$6,216,000,000.00
$922,003,000.00
Revenue This Year
$0.45
$3.92
Revenue Next Year
$1.67
$4.12
P/E Ratio
$24.49
$16.61
Revenue Growth
N/A
7.79
52 Week Low
$5.69
$24.29
52 Week High
$13.49
$77.91

Technical Indicators

Market Signals
Indicator
OGN
CBZ
Relative Strength Index (RSI) 71.58 47.47
Support Level $10.05 $27.84
Resistance Level N/A $32.09
Average True Range (ATR) 0.05 1.80
MACD -0.08 -0.43
Stochastic Oscillator 95.83 43.99

Price Performance

Historical Comparison
OGN
CBZ

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.

Share on Social Networks: